Early Outcomes of the Myval THV vs Contemporary Valves in Individuals With Severe Symptomatic Native Aortic Stenosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
LANDMARK comparison of early outcomes of newer-generation Myval transcatheter heart valve series with contemporary valves (Sapien and Evolut) in real-world individuals with severe symptomatic native aortic stenosis: a randomised non-inferiority trial
Lancet 2024 May 22;[EPub Ahead of Print], A Baumbach, N van Royen, IJ Amat-Santos, M Hudec, M Bunc, A Ijsselmuiden, P Laanmets, D Unic, B Merkely, RS Hermanides, V Ninios, M Protasiewicz, BJWM Rensing, PL Martin, F Feres, M De Sousa Almeida, E van Belle, A Linke, A Ielasi, M Montorfano, M Webster, K Toutouzas, E Teiger, F Bedogni, M Voskuil, M Pan, O Angerås, WK Kim, J Rothe, I Kristić, V Peral, S Garg, H Elzomor, A Tobe, MC Morice, Y Onuma, O Soliman, PW SerruysFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.